BHCNYSEManufacturing

Bausch Health Companies Inc. (BHC) earnings date, market-implied expected move, and options open interest by expiry

8.21

−0.70 · −7.83%

post 8.20 −0.15%

Closed18:52 ET

Open8.77Volume8.9MMkt cap$3.1BEPS-2.27

Day8.14 – 8.938%52-wk4.33 – 9.0482%

BHC

Bausch Health Cos Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

—

Calendar

Last report

—

Linked news

40dXENE · customerXenon Pharmaceuticals Stock Sinks 31% After Pausing Depression Study Enrollment

News

Largest filed tie

13F top-10 QoQ

+4.28%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

221 managers

Top fund weight

0.00%

BHC weight · VT

N-PORTJul 31 '26

1 fund

Bausch Health Companies (BHC) is expected to report on Feb 22 after close (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 7 expiries · Oct 27 close

0.40OI · 7 expiries · Oct 27 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

4 nearer expiries

1570%Nov 66d0.091,716+15%0.09

3+50%Nov 1313d0.01523+2%0.01

1,089+6%Nov 2020d0.442,498+1%0.44

100−1%Nov 2727d2.1746+21%2.17

4840%Dec 1848d1.60303+3%1.60

12,986+2%Jan 1576d0.4231,2450%0.42

report · Feb 22 · after close · est.

5540%Apr 16167d1,3830%

ExpiryPutsCallsP/C

4 nearer expiries

Nov 66d1570%1,716+15%0.09

Nov 1313d3+50%523+2%0.01

Nov 2020d1,089+6%2,498+1%0.44

Nov 2727d100−1%46+21%2.17

Dec 1848d4840%303+3%1.60

Jan 1576d12,986+2%31,2450%0.42

report · Feb 22 · after close · est.

Apr 16167d5540%1,3830%0.40

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

15.16%as filednet margin · revenue +3.12% QoQ · +9.70% YoY

Revenue

$2.9B+3.12% QoQ

Gross profit

$2.2B+6.06% QoQ

75.01% margin

Operating income

$983M+32.84% QoQ

33.42% margin

Pre-tax income

$597M+71.55% QoQ

Net income

$446M+71.54% QoQ

15.16% margin

Cost of revenue

$735M−4.79% QoQ

Operating expenses

$1.2B−8.73% QoQ

SG&A $834M

R&D $141M

Other operating $11M

Other operating $237M

Other expense

$386M

Tax

$151M+71.59% QoQ

Revenue$2.9B+3.12%

Gross profit

$2.2B+6.06%

75.01% margin

Operating income

$983M+32.84%

33.42% margin

Pre-tax income

$597M+71.55%

Net income

$446M+71.54%

15.16% margin

Cost of revenue

$735M−4.79%

Operating expenses

$1.2B−8.73%

SG&A $834M

R&D $141M

Other operating $11M

Other expense

$386M

Tax$151M+71.59%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 18:45 ET

Intraday

Event sensitivity

PCE ×1.87· ±4.2% vs ±2.2% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±4.2%9 of 19×1.87

GDPgross domestic product±3.7%9 of 19×1.66

FOMCrate decision±2.9%11 of 24×1.30

NFPjobs report±2.5%6 of 10×1.11

PPIproducer prices±2.1%5 of 11×0.97

CPROFcorporate profits±2.0%7 of 12×0.89

CPIconsumer prices±1.3%5 of 11×0.58

Bar = avg |move| to ±5% · tick = ±2.2% avg day · ×base = |move| ÷ ±2.2% · min 6 releases

Earnings history

EPS 1.15 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	1.15	—
Q2 FY26	—	0.68	—
Q1 FY26	—	-3.82	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod